Abstract

Therapeutic Area Partnerships is a uniquely efficient gathering bringing together decision-makers to assess the most promising drug programs available for partnering in Cardiovascular/Metabolic Diseases, Neuroscience, Anti-Inflammatory/Autoimmune Diseases, Oncology/Immuno Oncology, Infectious and Emerging Diseases, Advanced Therapies (Cell, Gene and Stem Therapies), Orphan and Rare Diseases, and Academic Technology Transfer.